ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Galectin Therapeutics Inc

Galectin Therapeutics Inc (GALT)

1.95
0.00
(0.00%)
Closed 12 December 8:00AM
0.00
0.00
(0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -8.12M-10.63M-10.34M-9M-9.17M-9.56M-9.65M-11.29M
Pre Tax Income -8.6M-10.63M-11.53M-9.11M-10.43M-10M-11.49M-12.37M
Net Income -8.58M-10.7M-11.53M-9.18M-14.04M-10.06M-11.5M-12.44M
Preferred Dividends 16k-65k0-63k-3.61M-63k-8k-64k
Basic Earnings Per Share (EPS) 00000000
EBIT -8.12M-10.63M-10.34M-9M-9.17M-9.56M-9.65M-11.29M
EBITDA -8.1M-10.66M-10.34M-9M-9.14M-9.59M-9.65M-11.29M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -21.48M-16.25M-13.6M-13.44M-23.44M-30.18M-38.35M-38.07M
Pre Tax Income -21.44M-16.24M-13.9M-13.29M-23.47M-30.53M-38.78M-41.07M
Net Income -22.35M-17.47M-15.05M-20.18M-23.6M-30.7M-38.87M-44.81M
Preferred Dividends -741k-1.23M-1.15M-263k-137k-171k-97k-3.74M
Basic Earnings Per Share (EPS) -0.509-0.374-0.261-0.253-0.295-0.373-0.472-0.529
EBIT -21.48M-16.25M-13.6M-13.44M-23.44M-30.18M-38.35M-38.07M
EBITDA -21.47M-16.25M-13.6M-13.44M-23.41M-30.14M-38.35M-38.07M